Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorOLIVEIRA, Deborah
dc.contributor.authorOTUYAMA, Leonardo Jun
dc.contributor.authorMABUNDA, Dirceu
dc.contributor.authorMANDLATE, Flavin
dc.contributor.authorGONCALVES-PEREIRA, Manuel
dc.contributor.authorXAVIER, Miguel
dc.contributor.authorLAKS, Jerson
dc.contributor.authorFERRI, Cleusa P.
dc.identifier.citationJOURNAL OF ALZHEIMERS DISEASE, v.70, suppl.1, p.S283-S291, 2019
dc.description.abstractBackground: Most people with dementia live in low- and middle-income countries and little is known about the potential for reducing these numbers by reducing key risk factors. Objective: To investigate the potential for dementia incidence reduction in Brazil, Mozambique, and Portugal (a culturally related, high-income country). Methods: We replicated previously published methods and based on the relative risks from previous studies, we estimated the population-attributable risk (PAR) of dementia in Mozambique, Brazil, and Portugal for seven modifiable risk factors associated with dementia (low educational attainment, physical inactivity, midlife hypertension, midlife obesity, depression, smoking, and diabetes mellitus). The combined PAR was calculated and adjusted for associations between risk factors. The potential for risk factor reduction was assessed by examining the effect of relative reductions of 10% and 20% per decade for each of the risk factors on projections for dementia cases for each decade until 2050. Results: After adjusting for non-independence of risk factors, 24.4%, 32.3%, and 40.1% of dementia cases could be related to seven potentially modifiable risk factors in Mozambique, Brazil, and Portugal, respectively. Reducing the prevalence of each risk factor by 20% per decade could, by 2050, potentially reduce the prevalence of dementia in Mozambique, Brazil, and Portugal by 12.9%, 16.2%, and 19.5%, respectively. Conclusion: There is a substantial difference between the countries in the percentage of dementia cases that could be attributable to the seven potentially modifiable risk factors. The proportion of cases that could be prevented by 2050 if measures were taken to address these main risk factors was higher in Portugal than in Brazil and Mozambique. Each country or region should consider their unique risk factor profile when developing dementia risk reduction programs.eng
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)
dc.description.sponsorshipConselho Nacional de Pesquisa (CNPq)
dc.description.sponsorshipAssociacao Fundo de Incentivo a Pesquisa (AFIP)
dc.publisherIOS PRESSeng
dc.relation.ispartofJournal of Alzheimers Disease
dc.subjectAlzheimer's diseaseeng
dc.subjectlow- and middle-income countrieseng
dc.subjectrisk reductioneng
dc.subject.otherurban/rural gapeng
dc.titleReducing the Number of People with Dementia Through Primary Prevention in Mozambique, Brazil, and Portugal: An Analysis of Population-Based Dataeng
dc.rights.holderCopyright IOS PRESSeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng, Deborah:Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil; Univ Fed Sao Paulo, Dept Psychiat, Sao Paulo, Brazil, Dirceu:Eduardo Mondlane Univ, Fac Med, Maputo, Mozambique, Flavin:Eduardo Mondlane Univ, Fac Med, Maputo, Mozambique, Manuel:Univ Nova Lisboa, Nova Med Sch, Fac Ciencias Med, Lisbon, Portugal, Miguel:Univ Nova Lisboa, Nova Med Sch, Fac Ciencias Med, Lisbon, Portugal, Jerson:Univ Fed Rio de Janeiro, Duque De Caxias, RJ, Brazil; Univ Grande Rio, Duque De Caxias, RJ, Brazil, Cleusa P.:Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil; Univ Fed Sao Paulo, Dept Psychiat, Sao Paulo, Brazil; Hosp Alemao Osvaldo Cruz, Hlth Technol Assessment Unit, Sao Paulo, Brazil
hcfmusp.description.issuesuppl 1
hcfmusp.relation.referenceAshby-Mitchell K, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0238-xeng
hcfmusp.relation.referenceAudet CM, 2018, J AFFECT DISORDERS, V227, P48, DOI 10.1016/j.jad.2017.10.022eng
hcfmusp.relation.referenceBarnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2eng
hcfmusp.relation.referenceBarreto M, 2015, 1 INQUERITO NACL SAUeng
hcfmusp.relation.referenceCarreira H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-958eng
hcfmusp.relation.referenceChipembe CS, 2015, RALATORIO FINAL INQUeng
hcfmusp.relation.referenceDamasceno A, 2009, HYPERTENSION, V54, P77, DOI 10.1161/HYPERTENSIONAHA.109.132423eng
hcfmusp.relation.referenceFagundes SD, 2011, SAO PAULO MED J, V129, P46, DOI 10.1590/S1516-31802011000100009eng
hcfmusp.relation.referenceFerretti C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193209eng
hcfmusp.relation.referenceFrankish H, 2017, LANCET, V390, P2614, DOI 10.1016/S0140-6736(17)31756-7eng
hcfmusp.relation.referenceGomes A, 2010, OBES REV, V11, P627, DOI 10.1111/j.1467-789X.2010.00739.xeng
hcfmusp.relation.referenceGoncalves-Pereira M, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0647-5eng
hcfmusp.relation.referenceLEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531eng
hcfmusp.relation.referenceLivingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6eng
hcfmusp.relation.referenceNakamura AE, 2015, LANCET, V385, P418, DOI 10.1016/S0140-6736(15)60153-2eng
hcfmusp.relation.referenceNorton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-Xeng
hcfmusp.relation.referenceOECD, 2014, ED GLANC 2014 OECD I, DOI [10.1787/eag-2014-en, DOI 10.1787/EAG-2014-EN]eng
hcfmusp.relation.referencePadrao P, 2013, NICOTINE TOB RES, V15, P199, DOI 10.1093/ntr/nts111eng
hcfmusp.relation.referencePadrao P, 2012, PREV MED, V55, P444, DOI 10.1016/j.ypmed.2012.08.006eng
hcfmusp.relation.referencePrince M., 2015, WORLD ALZHEIMER REPOeng
hcfmusp.relation.referenceRosenberg A, 2018, ALZHEIMERS DEMENT, V14, P263, DOI 10.1016/j.jalz.2017.09.006eng
hcfmusp.relation.referenceSilva-Matos C, 2011, DIABETES METAB, V37, P237, DOI 10.1016/j.diabet.2010.10.006eng
hcfmusp.relation.referenceWorld Health Organization, 2013, PORT WHO COUNTR PROFeng
hcfmusp.relation.referenceWorld Health Organization (WHO), 2009, GLOB HLTH RISKS MORTeng
Appears in Collections:

Artigos e Materiais de Revistas Científicas - HC/InRad
Instituto de Radiologia - HC/InRad

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar

Files in This Item:
File Description SizeFormat 
  Restricted Access
260.44 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.